108 related articles for article (PubMed ID: 2536954)
1. Transformation and plasmacytoid differentiation of EBV-infected human B lymphoblasts by ras oncogenes.
Seremetis S; Inghirami G; Ferrero D; Newcomb EW; Knowles DM; Dotto GP; Dalla-Favera R
Science; 1989 Feb; 243(4891):660-3. PubMed ID: 2536954
[TBL] [Abstract][Full Text] [Related]
2. Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity.
Scala G; Quinto I; Ruocco MR; Arcucci A; Mallardo M; Caretto P; Forni G; Venuta S
J Exp Med; 1990 Jul; 172(1):61-8. PubMed ID: 2162905
[TBL] [Abstract][Full Text] [Related]
3. Different biological effects of c-myc and H-ras oncogene expression in EBV-infected human lymphoblasts.
Seremetis S; Inghirami G; Ferrero D; Lombardi L; Knowlest DM; Dotto GP; Dalla-Favera R
Curr Top Microbiol Immunol; 1988; 141():290-7. PubMed ID: 2850896
[No Abstract] [Full Text] [Related]
4. [Studies on transforming functions of Epstein-Barr virus-specific proteins].
Kinoshita T
Hokkaido Igaku Zasshi; 1990 Jul; 65(4):362-75. PubMed ID: 2172130
[TBL] [Abstract][Full Text] [Related]
5. Induction of the neoplastic phenotype of EBV-established B lymphocytes by the human Ha-ras oncogene.
Nasi S; Sirinian MI; Panetta G; Marchetti A; Jucker R
Oncogene; 1990 Jan; 5(1):117-22. PubMed ID: 2157177
[TBL] [Abstract][Full Text] [Related]
6. Modulation of LFA-1 surface antigen expression by activated H-ras oncogene in EBV-infected human B-lymphoblast cells.
Endo K; Borer CH; Tsujimoto Y
Oncogene; 1991 Aug; 6(8):1391-6. PubMed ID: 1653411
[TBL] [Abstract][Full Text] [Related]
7. Process of immortalization by Epstein-Barr virus and oncogenic conversion of the immortalized cells.
Nonoyama M; Tanaka A; Ozaki H
AIDS Res; 1986 Dec; 2 Suppl 1():S103-8. PubMed ID: 2881553
[TBL] [Abstract][Full Text] [Related]
8. Ras oncogene transformation of human B lymphoblasts is associated with lymphocyte activation and with a block of differentiation.
Sirinian MI; Marchetti A; Di Rocco G; Starace G; Jucker R; Nasi S
Oncogene; 1993 Jan; 8(1):157-63. PubMed ID: 8423993
[TBL] [Abstract][Full Text] [Related]
9. Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease.
Tanner JE; Alfieri C
Leuk Lymphoma; 1996 May; 21(5-6):379-90. PubMed ID: 9172802
[TBL] [Abstract][Full Text] [Related]
10. Generation of human monoclonal antibodies by transformation of lymphoblastoid B cells with ras oncogene.
Shammah S; Mantovani TL; Dalla-Favera R; Casali P
J Immunol Methods; 1993 Mar; 160(1):19-25. PubMed ID: 8450236
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 and c-Myc co-operate in the Epstein-Barr virus-immortalized human B-cell line GM607 but do not confer tumorigenicity.
Tomlin JL; Guinn BA; Penn LZ; Berinstein NL
Leuk Lymphoma; 2005 Apr; 46(4):581-92. PubMed ID: 16019487
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the human BCL-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells.
Tsujimoto Y
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1958-62. PubMed ID: 2538824
[TBL] [Abstract][Full Text] [Related]
13. Introduction of the activated N-ras oncogene into human fibroblasts by retroviral vector induces morphological transformation and tumorigenicity.
Kinsella AR; Fiszer-Maliszewska L; Mitchell EL; Guo YP; Fox M; Scott D
Carcinogenesis; 1990 Oct; 11(10):1803-9. PubMed ID: 2208593
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress enables Epstein-Barr virus-induced B-cell transformation by posttranscriptional regulation of viral and cellular growth-promoting factors.
Chen X; Kamranvar SA; Masucci MG
Oncogene; 2016 Jul; 35(29):3807-16. PubMed ID: 26592445
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus activates c-myc and Epstein-Barr virus in human B lymphocytes.
Astrin SM; Laurence J
Ann N Y Acad Sci; 1992 May; 651():422-32. PubMed ID: 1318011
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus induction of malignant transformation in human B lymphocytes.
Laurence J; Astrin SM
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7635-9. PubMed ID: 1652756
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic, cytogenetic and molecular characterization of a new B-chronic lymphocytic leukaemia (B-CLL) cell line.
Caligaris-Cappio F; Bergui L; Rege-Cambrin G; Tesio L; Migone N; Malavasi F
Leuk Res; 1987; 11(7):579-88. PubMed ID: 3039258
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone-dependent inhibition of differentiation of C2 myoblasts bearing steroid-inducible N-ras oncogenes.
Gossett LA; Zhang W; Olson EN
J Cell Biol; 1988 Jun; 106(6):2127-37. PubMed ID: 3133379
[TBL] [Abstract][Full Text] [Related]
19. Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes.
Rochford R; Hobbs MV; Garnier JL; Cooper NR; Cannon MJ
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):352-6. PubMed ID: 8380497
[TBL] [Abstract][Full Text] [Related]
20. Expression of the oncogenes mil and ras abolishes the in vivo differentiation of mammary epithelial cells.
Günzburg WH; Salmons B; Schlaeffli A; Moritz-Legrand S; Jones W; Sarkar NH; Ullrich R
Carcinogenesis; 1988 Oct; 9(10):1849-56. PubMed ID: 3048764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
